contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


biostock-spago-we-are-really-encouraged-by-how-the-trial-is-progressing

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Spago Nanomedical är verksamt inom bioteknik. Bolaget utvecklar nanomedicin för diagnostik och behandling av livshotande sjukdomar. Bolagets huvudsakliga verksamhet är inriktad mot att utveckla ett cancerselektivt kontrastmedel för magnetisk resonanstomografi (MR), samt en produkt för radionuklidbehandling av cancer. Båda dessa projekt är baserade på egenutvecklade nanomaterial. Störst verksamhet återfinns inom den nordiska marknaden, med huvudkontoret beläget i Lund.

Spago Nanomedical

Spago Nanomedical has recently presented promising data from the ongoing phase I/IIa study Tumorad-01, where the company's candidate shows clear tumour uptake and a continued good safety profile...

<div class="mfn-preamble"><p><strong>Spago Nanomedical has recently presented promising data from the ongoing phase I/IIa study Tumorad-01, where the company's candidate shows clear tumour uptake and a continued good safety profile. The results are considered proof-of-concept and mark an important step forward in the development. CEO Mats Hansen and CDO Paul Hargreaves visited BioStock's studio to talk more about the significance of the latest results, what is next in the program - and how they see the company's commercial opportunities going forward.</strong></p></div><div class="mfn-body"><p>See the interview biostock.se:<br><a rel="noopener" href="https://biostock.se/en/2025/10/spagowe-are-really-encouraged-by-how-the-trial-is-progressing/">https://biostock.se/en/2025/10/spagowe-are-really-encouraged-by-how-the-trial-is-progressing/</a><br>&nbsp;<br>This is a press release from <strong>BioStock - Connecting Innovation &amp; Capital</strong>. <a rel="noopener" href="https://www.biostock.se/">https://www.biostock.se/</a></p></div><div class="mfn-footer mfn-about mfn-e63cb96431c5"><p><strong class="mfn-heading-1">Follow BioStock</strong><br>Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at <a rel="noopener" href="https://www.biostock.se/newsletter">https://www.biostock.se/newsletter</a>&nbsp;<br>Follow BioStock on social media: <a rel="noopener" href="https://www.linkedin.com/company/biostock/">LinkedIn</a> and <a rel="noopener" href="https://www.facebook.com/biostock.se%22%20/t%20%22_blank">Facebook</a>! &nbsp;<br>&nbsp;<br><strong>About BioStock</strong>&nbsp;<br>BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.&nbsp;&nbsp;<br>BioStock – Connecting Innovation &amp; Capital.&nbsp;</p></div>